Polymorphisms in the TRPV1 gene are associated with increased pain sensitivity and response to botulinum toxin therapy, highlighting its significance in the inflammatory and nociceptive processes in migraines [78,79]. This evidence concerns the gene TRPV1 and migraine disorder.